<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Endocrinol</journal-id><journal-id journal-id-type="iso-abbrev">Int J Endocrinol</journal-id><journal-id journal-id-type="publisher-id">IJE</journal-id><journal-title-group><journal-title>International Journal of Endocrinology</journal-title></journal-title-group><issn pub-type="ppub">1687-8337</issn><issn pub-type="epub">1687-8345</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7206888</article-id><article-id pub-id-type="doi">10.1155/2020/3260728</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>BK<sub>Ca</sub> Mediates Dysfunction in High Glucose Induced Mesangial Cell Injury via TGF-<italic>&#x003b2;</italic>1/Smad2/3 Signaling Pathways</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Zhigui</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Wenxian</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Mengqi</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Si</surname><given-names>Yuankai</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Xiaoxiao</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1293-1238</contrib-id><name><surname>Chen</surname><given-names>Meijuan</given-names></name><email>chenmeijuan1969@sina.com</email><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Department of Pharmacy, Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China</aff><aff id="I2">
<sup>2</sup>Department of Pharmacy, Affiliated Hospital of Traditional Chinese Medicine Southwest Medical University, Luzhou 646000, Sichuan, China</aff><aff id="I3">
<sup>3</sup>Department of Pharmacy, Southwest Medical University, Luzhou 646000, Sichuan, China</aff><author-notes><fn fn-type="other"><p>Academic Editor: Silvia Monticone</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>29</day><month>4</month><year>2020</year></pub-date><volume>2020</volume><elocation-id>3260728</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>11</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Zhigui Wu et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p> To explore the role and mechanism of BK<sub>Ca</sub> in diabetic kidney disease. </p></sec><sec><title>Methods</title><p> Rat mesangial cells (MCs) HBZY-1 were cultured with high glucose to simulate the high-glucose environment of diabetic kidney disease in vivo. The effects of large conductance calcium-activated potassium channel (BK<sub>Ca</sub>) on proliferation, migration, and apoptosis of HBZY-1 cells were observed. The contents of transforming growth factor beta 1 (TGF-<italic>&#x003b2;</italic>1), Smad2/3, collagen IV (Col IV), and fibronectin (FN) in the extracellular matrix were also observed. </p></sec><sec><title>Results</title><p> High glucose significantly damaged HBZY-1 cells, which enhanced the ability of cell proliferation, migration, and apoptosis, and increased the secretion of Col IV and FN. Inhibition of BK<sub>Ca</sub> and TGF-<italic>&#x003b2;</italic>1/Smad2/3 signaling pathways can inhibit the proliferation, migration, and apoptosis of HBZY-1 cells and suppress the secretion of Col IV and FN. The effect of excitation is the opposite. </p></sec><sec><title>Conclusions</title><p> BK<sub>Ca</sub> regulates mesangial cell proliferation, migration, apoptosis, and secretion of Col IV and FN and is associated with TGF-<italic>&#x003b2;</italic>1/Smad2/3 signaling pathway.</p></sec></abstract><funding-group><award-group><funding-source>Project of Doctoral Research Initiation Foundation of Affiliated Hospital of Southwest Medical University</funding-source><award-id>18104</award-id></award-group><award-group><funding-source>Project of Southwest Medical University</funding-source><award-id>31260</award-id></award-group><award-group><funding-source>Project of Sichuan Health Department</funding-source><award-id>050102</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>The diagnosis of type 2 diabetes mellitus (T2DM), the majority of diabetes mellitus (DM), is often accompanied by chronic microvascular or macrovascular complications with high economic and social costs, among which are diabetic kidney disease (DKD), retinopathy, peripheral blood vessels, and coronary atherosclerosis. About 30% of DM patients suffer from DKD, the leading cause of end-stage kidney disease (ESKD) and even premature death [<xref rid="B1" ref-type="bibr">1</xref>]. Glomerulus is currently regarded as the main site of lesions of DKD with the main pathological features being diffuse mesangial matrix dilatation, exudative lesions and segmental nodular sclerosis in the glomeruli [<xref rid="B2" ref-type="bibr">2</xref>], accumulation of the extracellular matrix (ECM) in the glomerulus and tubulointerstitial septal compartment [<xref rid="B3" ref-type="bibr">3</xref>], and thickening and transparency of the intrarenal vascular system [<xref rid="B4" ref-type="bibr">4</xref>]. Glomerular mesangial cells (MCs) are involved in many physiological activities, such as the production of growth factors, the formation of glomerular mesangial matrix as the structural support of capillaries, and the regulation of glomerular hemodynamics by contractile properties [<xref rid="B5" ref-type="bibr">5</xref>]. When the glomerulus is damaged, MCs often change their phenotype to myofibroblasts expressing <italic>&#x003b1;</italic>-smooth muscle actin or interstitial collagen besides normal matrix components, which is a key link of glomerulosclerosis [<xref rid="B6" ref-type="bibr">6</xref>]. Despite many strategies proven effective, including control of blood sugar and blood pressure and inhibition of the renin-angiotensin-aldosterone system (RAAS), the number of DM patients who eventually develop DKD is still large [<xref rid="B7" ref-type="bibr">7</xref>]. Therefore, it is still vital to find new therapeutic targets for preventing and delaying the progress of DKD.</p><p>BK<sub>Ca</sub> is considered to be a key participant in many physiological functions, including regulating neuronal discharge [<xref rid="B8" ref-type="bibr">8</xref>], smoothing muscle tension [<xref rid="B9" ref-type="bibr">9</xref>], promoting endocrine cell secretion [<xref rid="B10" ref-type="bibr">10</xref>], cell proliferation and migration [<xref rid="B11" ref-type="bibr">11</xref>], etc. It also participates in a series of diseases, such as hypertension, epilepsy, cancer, and so on [<xref rid="B12" ref-type="bibr">12</xref>]. Recently, BK channel subtypes were also found in glomerular podocytes and mesangial cells [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B13" ref-type="bibr">13</xref>]. Our previous studies found that BK<sub>Ca</sub> channel expression was downregulated and the current density of the BK<sub>Ca</sub> channel was downregulated in diabetic coronary artery smooth muscle cells [<xref rid="B14" ref-type="bibr">14</xref>]. TGF-<italic>&#x003b2;</italic>1 is a key regulator of ECM synthesis and degradation in diabetic nephropathy [<xref rid="B15" ref-type="bibr">15</xref>], which promotes renal fibrosis by upregulating the gene encoding ECM proteins and enhancing the production of ECM degrading enzyme inhibitors to inhibit its degradation [<xref rid="B16" ref-type="bibr">16</xref>]. TGF-<italic>&#x003b2;</italic>1 first binds to the membrane TGF-<italic>&#x003b2;</italic>II receptor and complexes are transphosphorylated to reactivate type I receptor, and then it activates Smad signaling pathway and regulates the transcription of TGF-<italic>&#x003b2;</italic>1 target genes, such as Col IV and FN, through phosphorylation of Smad 2/3 and translocation into the nucleus [<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>].</p><p>At present, no research has focused on the relationship between BK<sub>Ca</sub> and MCs. However, BK<sub>Ca</sub> participates in cell proliferation and migration and can regulate the secretion of endocrine cells; MCs can secrete mesangial matrix, transform the phenotype into fibroblasts under stress, and participate in glomerulosclerosis. Due to the similar function between the two, it is worth further exploring their internal relationship.</p><p>In this study, HBZY-1 cells were cultured with high glucose to establish the DKD cell model. The effects of inhibiting or activating BK<sub>Ca</sub> on the proliferation, migration, and apoptosis of HBZY-1 cells, as well as the changes of TGF-<italic>&#x003b2;</italic>1, Smad2/3, and ECM (Col IV, FN) were observed to explore the role of BK<sub>Ca</sub> in DKD and its mechanism, so as to provide new ideas for the clinical treatment and drug development of DKD.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Morphological Characteristics and Experimental Grouping of HBZY-1 Cells</title><p>The morphological characteristics of HBZY-1 cells (purchased from the China Center for Type Culture Collection) under high- and low-sugar conditions (cultured with 10% fetal bovine serum, 100&#x02009;U/ml penicillin, and 100&#x02009;mg/ml streptomycin at 37&#x000b0;C in 95% air and 5% CO<sub>2</sub>) were observed under a microscope, and the cells at logarithmic growth stage were selected for experiment. The cells were transfected with BK<sub>Ca</sub>-siRNA (the details of RNA interference are available in the supplementary materials). The mesangial cells were intervened with BKCa agonist NS11021 [<xref rid="B19" ref-type="bibr">19</xref>] or inhibitor tetrandrine (Tet) [<xref rid="B20" ref-type="bibr">20</xref>]and TGF-<italic>&#x003b2;</italic>1 or inhibitor SB431542 [<xref rid="B21" ref-type="bibr">21</xref>].</p><p>The experiment was divided into 9 groups: low-glucose control group (NG, 5.5&#x02009;mmol/L glucose), high-glucose control group (HG, 24.5&#x02009;mmol/L glucose), BK<sub>Ca</sub>-siRNA group (HG&#x02009;+&#x02009;BK<sub>Ca</sub> gene expression inhibition), Tet group (HG&#x02009;+&#x02009;Tet 10&#x02009;<italic>&#x003bc;</italic>M), NS11021 group (HG&#x02009;+&#x02009;NS11021 10&#x02009;<italic>&#x003bc;</italic>M), TGF-<italic>&#x003b2;</italic>1 group (HG&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>12&#x02009;ng/ml), SB431542 group (HG&#x02009;+&#x02009;SB431542 10&#x02009;<italic>&#x003bc;</italic>M), NS11021&#x02009;+&#x02009;SB1442 group (HG&#x02009;+&#x02009;NS11021 10&#x02009;<italic>&#x003bc;</italic>M&#x02009;+&#x02009;SB431542 10&#x02009;<italic>&#x003bc;</italic>M), and Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 group (HG&#x02009;+&#x02009;Tet 10&#x02009;<italic>&#x003bc;</italic>M&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>12&#x02009;ng/ml).</p></sec><sec id="sec2.2"><title>2.2. Mesangial Cell Proliferation</title><p>MTT was used to measure the cell survival rate to calculate the proliferation. The cells were counted and the density was adjusted to 5&#x02009;&#x000d7;&#x02009;10<sup>4</sup> and then inoculated into 96-well plates at 37&#x000b0;C in a 5% CO<sub>2</sub> incubator for 24 hours. Then corresponding intervention drugs were added according to the experimental design; 5&#x02009;ml MTT solution was added to each hole, and then the cells were cultured for 4 hours. The supernatant should be absorbed and discarded, and 150&#x02009;<italic>&#x003bc;</italic>L of DMSO was added to each well. They were shaken for 10 minutes. After crystallization was completely dissolved, the OD value (absorbance) at 490&#x02009;nm wavelength of each pore was detected by using enzyme labeling instrument.</p><p>The cell survival rate was calculated by the following equation: (OD administration&#x02009;&#x02212;&#x02009;OD blank)/(OD control&#x02009;&#x02212;&#x02009;OD blank)<italic>&#x02217;</italic>100%.</p></sec><sec id="sec2.3"><title>2.3. HBZY-1 Cell Migration</title><p>Three horizontal lines were first drawn evenly in each hole back of the 6-well plate, and then HBZY-1 cells were cultured with a density of 12&#x02009;&#x000d7;&#x02009;10<sup>4</sup> at 37&#x000b0;C in a 5% CO<sub>2</sub> incubator for 24 hours. Then, 3 scratches were made in the cells evenly in each hole perpendicular to the previous horizontal line with the tip of the pipette and continually cultured for grouping intervention; photographs were taken at 0 and 48 hours, and the scratch area was calculated by image J software. Use ImageJ software to open the picture to be analyzed. Under the Process project, click Enhance Contrast, select Normalize, adjust the Saturated pixels to 0.3%, and then select Smooth and Find Edges under the Process project. After that, select Adjust-Threshold under the Image item, select Red, and adjust the threshold to 0&#x02212;20. Finally, use the magic wand tool to select the black scratches and select Measure under the Analyze project to get the scratch area. Wound healing percentage&#x02009;=&#x02009;initial scratch area/scratch area at a point in time.</p></sec><sec id="sec2.4"><title>2.4. Hoechst Dyeing Experiment</title><p>HBZY-1 cells were cultured into 6-well plates at 8&#x02009;&#x000d7;&#x02009;10<sup>4</sup> density at 37&#x000b0;C in a 5% CO<sub>2</sub> incubator for 24 hours. The cells were intervened by adding drugs in groups after 48 hours, the supernatant was discarded, and 4% polyformaldehyde fixed solution and Hoechst 33258 staining solution were added to each hole, respectively. After discarding the staining solution, the cell staining was observed under an inverted fluorescence microscope and then photographed, recorded, and analyzed.</p></sec><sec id="sec2.5"><title>2.5. Annexin V-FITC/PI Double-Staining Experiment</title><p>HBZY-1 cells were planted into 6-well plates at 12&#x02009;&#x000d7;&#x02009;104 density. The cells were cultured at 37&#x000b0;C in a 5% CO<sub>2</sub> incubator for 24 hours, then treated in groups, and cultured for 48 hours to be collected. A small amount of 1&#x02009;&#x000d7;&#x02009;binding buffer was added to adjust cell density with 10&#x02009;&#x000d7;&#x02009;10<sup>5</sup>. After labeling, 100&#x02009;ml cell suspension was added to each tube, and 5&#x02009;ml Annexin V-FITC and 5&#x02009;ml PI staining solution were added to each tube and then detected by a flow cytometer. The results were analyzed by Flowjo software.</p></sec><sec id="sec2.6"><title>2.6. Expression of BK<sub>Ca</sub>-<italic>&#x003b1;</italic>, <italic>&#x003b2;</italic>, Col IV, and FN Protein in HBZY-1Cells</title><p>Proteins extracted from the HBZY-1 cells were analyzed by Western blotting. Equal amounts of protein (about 50&#x02009;<italic>&#x003bc;</italic>g) were subjected to SDS-PAGE and transferred to a PVDF membrane, then blocked in 5% skimmed milk for 2 hours at room temperature, and then incubated overnight at 4&#x000b0;C with the following primary antibodies according to the instructions: anti-BK<sub>Ca</sub>-<italic>&#x003b1;</italic>, anti-BK<sub>Ca</sub>-<italic>&#x003b2;</italic>, anti-Col IV, anti-FN, and anti-<italic>&#x003b2;</italic>-actin (Abcam Biotechnology, USA). The membranes were then incubated with HRP-conjugated secondary anti-mouse antibody (Abcam Biotechnology, USA). Protein bands on the membrane were visualized by ECL (electrochemiluminescence) (ThermoScientific, Rockford, IL, USA) and quantitated using QuantityOne software (Bio-Rad, Richmond, CA, USA). Image J software was used to open the strip picture to get the gray statistics of the selected area.</p></sec><sec id="sec2.7"><title>2.7. Detection of TGF-<italic>&#x003b2;</italic>1 and Smad2/3 in Cell Supernatant by ELISA</title><p>HBZY-1 cells were inoculated into 6-well plates at 12&#x02009;&#x000d7;&#x02009;10<sup>4</sup> density at 37&#x000b0;C in a 5% CO<sub>2</sub> incubator for 24 hours and then cultured for 48 hours after intervention by grouping administration. Cell culture medium was absorbed and centrifuged at 4&#x000b0;C and 8000&#x02009;rpm/min for 15 minutes. Only the supernatant was taken and operated according to ELISA guidelines.</p></sec><sec id="sec2.8"><title>2.8. Statistical Analysis</title><p>The experimental data were analyzed with SPSS 19.0 software (IBM, Armonk, NY, USA). The data were expressed as means&#x02009;&#x000b1;&#x02009;standard deviations. <italic>T</italic>-test analysis was used for comparisons between two groups. One-way ANOVA was used for comparisons among multiple groups. <italic>P</italic> &#x0003c; 0.05 indicated that the difference was statistically significant.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. The Results of BK<sub>Ca</sub>-siRNA Transfection and NS11021 and Tet Pre-Experimental Concentration Selection</title><p>BK<sub>Ca</sub>-siRNA was successful transfection (seen Supplementary <xref ref-type="supplementary-material" rid="supplementary-material-1">Figure 1</xref>), and finally BK<sub>Ca</sub>-<italic>&#x003b1;</italic>-1188 was selected to continue the subsequent experiment for the gene inhibition group (Supplementary <xref ref-type="supplementary-material" rid="supplementary-material-1">Figure 2</xref>). In order to select the optimum concentration of NS11021 and Tet, a series of experiments were conducted to confirm the concentrations of NS11021 and Tet as 10&#x02009;<italic>&#x003bc;</italic>M in this study. The detailed results are given in Supplementary <xref ref-type="supplementary-material" rid="supplementary-material-1">Figure 3</xref>.</p></sec><sec id="sec3.2"><title>3.2. Inhibition of BK<sub>Ca</sub> and TGF-<italic>&#x003b2;</italic>1 Can Inhibit the Proliferation of Glomerular Mesangial Cells</title><p>Compared with the NG group, cell proliferation in the HG group increased significantly (<italic>P</italic> &#x0003c; 0.01). Compared with the HG group, NS11021 promoted cell proliferation (<italic>P</italic> &#x0003c; 0.01), Tet and BK<sub>Ca</sub>-siRNA inhibited cell proliferation (<italic>P</italic> &#x0003c; 0.01), TGF-<italic>&#x003b2;</italic>1 promoted cell proliferation (<italic>P</italic> &#x0003c; 0.01), SB431542 inhibited cell proliferation (<italic>P</italic> &#x0003c; 0.01), Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 promoted cell proliferation (<italic>P</italic> &#x0003c; 0.01), and NS11021&#x02009;+&#x02009;SB431542 inhibited cell proliferation (<italic>P</italic> &#x0003c; 0.01) (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="sec3.3"><title>3.3. Inhibition of BK<sub>Ca</sub> and TGF-<italic>&#x003b2;</italic>1 Can Suppress the Migration of Mesangial Cells</title><p>Compared with the NG group, the healing rate of scratches in the HG group increased from 36% to 68% after 48 hours of intervention (<italic>P</italic> &#x0003c; 0.01), indicating that the transverse migration ability of cells increased (Figures <xref ref-type="fig" rid="fig2">2(a)</xref>, <xref ref-type="fig" rid="fig2">2(b)</xref>, and <xref ref-type="fig" rid="fig2">2(j)</xref>). Compared with the HG group, NS11021 enhanced cell migration (75%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig2">2(c)</xref> and <xref ref-type="fig" rid="fig2">2(j)</xref>), Tet decreased cell migration (39%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig2">2(d)</xref> and <xref ref-type="fig" rid="fig2">2(j)</xref>), BK<sub>Ca-</sub>siRNA decreased cell migration (38%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig2">2(e)</xref> and <xref ref-type="fig" rid="fig2">2(j)</xref>), TGF-<italic>&#x003b2;</italic>1 enhanced cell migration (77%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig2">2(f)</xref> and <xref ref-type="fig" rid="fig2">2(j)</xref>), SB431542 decreased cell migration ability (37%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig2">2(g)</xref> and <xref ref-type="fig" rid="fig2">2(j)</xref>), NS11021&#x02009;+&#x02009;SB431542 decreased cell migration ability (32%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig2">2(h)</xref> and <xref ref-type="fig" rid="fig2">2(j)</xref>), and Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 enhanced cell migration ability (78%, <italic>P</italic> &#x0003c; 0.05) (Figures <xref ref-type="fig" rid="fig2">2(i)</xref> and <xref ref-type="fig" rid="fig2">2(j)</xref>).</p></sec><sec id="sec3.4"><title>3.4. Inhibition of BK<sub>Ca</sub> Can Reduce the Apoptosis of Mesangial Cells</title><p>In the Hoechst staining experiment, the fluorescence intensity of the NG group, Tet group, BK<sub>Ca</sub>-siRNA group, SB431542 group, and NS11021&#x02009;+&#x02009;SB431542 group was lower, most of the cell nucleus and cytoplasm were light blue, and the fluorescence expression of chromatin was uniform. The fluorescence intensity of the NG group was the lowest, and the number of apoptotic cells was the lowest (Figures <xref ref-type="fig" rid="fig3">3(a)</xref>, <xref ref-type="fig" rid="fig3">3(d)</xref>, <xref ref-type="fig" rid="fig3">3(e)</xref>, <xref ref-type="fig" rid="fig3">3(g)</xref>, and <xref ref-type="fig" rid="fig3">3(h)</xref>). The fluorescence intensities of the HG group, NS11021 group, TGF-<italic>&#x003b2;</italic>1 group, and Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 group were high, some cell nucleus were concentrated and fragmented, and the whole staining fluorescence showed blue-white dense staining (Figures <xref ref-type="fig" rid="fig3">3(b)</xref>, <xref ref-type="fig" rid="fig3">3(c)</xref>, <xref ref-type="fig" rid="fig3">3(f)</xref>, and <xref ref-type="fig" rid="fig3">3(i)</xref>). These results suggest that inhibiting BK<sub>Ca</sub> can reduce the apoptosis of glomerular mesangial cells.</p><p>Flow cytometry was used to further detect the apoptotic status of each intervention group. Compared with the NG group, the apoptotic rate of the HG group increased from 7.6% to 22.1% after 48 hours of intervention (<italic>P</italic> &#x0003c; 0.01), indicating that apoptotic rate increased (Figures <xref ref-type="fig" rid="fig4">4(a)</xref>, <xref ref-type="fig" rid="fig4">4(b)</xref>, and <xref ref-type="fig" rid="fig4">4(j)</xref>). Compared with the HG group, the apoptotic rate of NS11021 cells increased (26.3%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig4">4(c)</xref> and <xref ref-type="fig" rid="fig4">4(j)</xref>). Tet cells decreased (18.6%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig4">4(d)</xref> and <xref ref-type="fig" rid="fig4">4(j)</xref>), and BK<sub>Ca</sub>-siRNA cells decreased (12.2%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig4">4(e)</xref> and <xref ref-type="fig" rid="fig4">4(j)</xref>). The apoptotic rate of TGF-<italic>&#x003b2;</italic>1 cells increased (25.6%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig4">4(f)</xref> and <xref ref-type="fig" rid="fig4">4(j)</xref>), SB4315). The apoptotic rate of 42 cells decreased (14.9%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig4">4(g)</xref> and <xref ref-type="fig" rid="fig4">4(j)</xref>). The apoptotic rate of NS11021&#x02009;+&#x02009;SB431542 cells decreased (15.7%, <italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig4">4(h)</xref> and <xref ref-type="fig" rid="fig4">4(j)</xref>). The apoptotic rate of Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 cells increased (27.7%, <italic>P</italic> &#x0003c; 0.01) (<xref ref-type="fig" rid="fig4">Figure 4(i)</xref>).</p></sec><sec id="sec3.5"><title>3.5. Inhibition of BK<sub>Ca</sub> Can Inhibit the Expression of Col IV and FN Protein in Glomerular Mesangial Cells</title><p>Compared with the NG group, the expression of BK<sub>Ca</sub>-<italic>&#x003b1;</italic> and <italic>&#x003b2;</italic> protein in the HG group increased 48 hours after intervention (<italic>P</italic> &#x0003c; 0.01). Compared with the HG group, the expression of BK<sub>Ca</sub>-<italic>&#x003b1;</italic> in NS11021 cells was insignificant (<italic>P</italic> &#x0003c; 0.05), while the expression of BK<sub>Ca</sub>-<italic>&#x003b2;</italic> in NS11021 cells increased (<italic>P</italic> &#x0003c; 0.01). Tet decreased the expression of BK<sub>Ca</sub>-<italic>&#x003b1;</italic> and <italic>&#x003b2;</italic> in NS11021 cells (<italic>P</italic> &#x0003c; 0.05), and BK<sub>Ca</sub>-siRNA decreased the expression of BK<sub>Ca</sub>-<italic>&#x003b1;</italic> and <italic>&#x003b2;</italic> in NS11021 cells (<italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig5">5(a)</xref>&#x02013;<xref ref-type="fig" rid="fig5">5(c)</xref>). Compared with SB431542, NS11021&#x02009;+&#x02009;SB431542, and Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1, the expression of BK<sub>Ca</sub>-<italic>&#x003b1;</italic> and <italic>&#x003b2;</italic> protein in cells was significantly different (<italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig5">5(d)</xref>&#x02013;<xref ref-type="fig" rid="fig5">5(f)</xref>).</p><p>Compared with the NG group, the expression of Col IV and FN in the HG group increased 48 hours after intervention (<italic>P</italic> &#x0003c; 0.01). Compared with the HG group, there was no significant difference in the expression of Col IV and FN in NS11021 cells (<italic>P</italic> &#x0003c; 0.05), Tet decreased the expression of Col IV and FN in NS11021 cells (<italic>P</italic> &#x0003c; 0.01), and BK<sub>Ca</sub>-siRNA decreased the expression of Col IV and FN in NS11021 cells (<italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig6">6(a)</xref>&#x02013;<xref ref-type="fig" rid="fig6">6(c)</xref>). Compared with SB431542, NS11021&#x02009;+&#x02009;SB431542, and Tet&#x02009;+&#x02009;TGF -<italic>&#x003b2;</italic>1, the expression of Col IV and FN in cells was significantly different (<italic>P</italic> &#x0003c; 0.01) (Figures <xref ref-type="fig" rid="fig6">6(d)</xref>&#x02013;<xref ref-type="fig" rid="fig6">6(f)</xref>).</p></sec><sec id="sec3.6"><title>3.6. Inhibition of BK<sub>Ca</sub> Can Inhibit the Expression of TGF-<italic>&#x003b2;</italic>1 and Smad2/3 in Supernatant of Mesangial Cells</title><p>Compared with the NG group, the expression of TGF-<italic>&#x003b2;</italic>1, and Smad2/3 increased in the HG group (<italic>P</italic> &#x0003c; 0.01). Compared with the HG group, the expression of Smad2/3 increased in the NS11021 group (<italic>P</italic> &#x0003c; 0.05), but the expression of TGF-<italic>&#x003b2;</italic>1 did not change significantly (<italic>P</italic> &#x0003c; 0.05); the expression of TGF-<italic>&#x003b2;</italic>1 and Smad2/3 decreased in the Tet group, BK<sub>Ca-</sub>siRNA group, SB431542 group, and NS11021&#x02009;+&#x02009;SB431542 group (<italic>P</italic> &#x0003c; 0.01); the expression of TGF-<italic>&#x003b2;</italic>1 increased significantly in the TGF-<italic>&#x003b2;</italic>1 group (<italic>P</italic> &#x0003c; 0.01), while the expression of Smad2/3 did not change significantly (<italic>P</italic> &#x0003c; 0.05). The expression of Smad2/3 increased (<italic>P</italic> &#x0003c; 0.05), but the difference of Smad2/3 expression was insignificant (<italic>P</italic> &#x0003c; 0.05) (Figures <xref ref-type="fig" rid="fig7">7(a)</xref> and <xref ref-type="fig" rid="fig7">7(b)</xref>).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>DKD is a common complication of DM, which is one of the three diseases with the highest incidence at present. Current research shows that the core of DKD is glomeruli [<xref rid="B5" ref-type="bibr">5</xref>]. MCs are the most active intrinsic cells in the glomerulus. They can be regulated by some cytokines to abnormally grow and secrete extracellular matrix when the glomerulus is damaged. They are important pathogenic factors leading to glomerulosclerosis [<xref rid="B22" ref-type="bibr">22</xref>]. As the most active intrinsic cell in the glomerulus, MCs can hypertrophy and proliferate in the early stage of DKD and further induce multidirectional signal pathways to affect renal function. The glomerular mesangial dilatation not only induces the secretion and deposition of macromolecule substances such as ECM but also squeezes the glomerular capillaries to make them narrow or even blocked and promotes the release of inflammatory mediators such as DKD-related cytokines and growth factors [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>]. Glomerular lesions of DKD include proliferation and hypertrophy of MCs, excessive accumulation of ECM in the form of abnormally increased mesangial matrix, and thickening of glomerular basement membrane, which eventually leads to nodular glomerulosclerosis [<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>]. Thus, abnormal proliferation, migration, apoptosis of MCs, and abnormal accumulation of ECM play a key role in the process of glomerular lesion. The results of cell proliferation, scratch, and apoptosis in this study showed that NS11021 could significantly promote the proliferation, migration, and apoptosis of HBZY-1 cells compared with the HG group. On the contrary, Tet and BK<sub>Ca</sub>-siRNA could significantly inhibit the proliferation, migration, and apoptosis of HBZY-1 cells. These results suggest that the proliferation, migration, and apoptosis of HBZY-1 cells can be inhibited by inhibiting BK<sub>Ca</sub>, thus improving glomerular lesions. It should be noted that the cell proliferation and apoptotic rate in the HG group increased at the same time, which is different from that in most experiments. It suggests that high glucose has a two-way effect of nutrition and damage to cells and can promote the proliferation and apoptosis of HBZY-1 cells at the same time. Compared with the HG group, NS11021 did not promote the secretion of Col IV and FN in HBZY-1 cells. The specific reason needs further study. It is suspected that the increasing open rate of BK<sub>Ca</sub> in high-glucose environment leads to the weak effect of agonists. However, Tet and BK<sub>Ca</sub>-siRNA can significantly inhibit the secretion of Col IV and FN in HBZY-1 cells. It is suggested that the secretion of Col IV and FN in ECM of HBZY-1 cells can be inhibited by inhibiting BK<sub>Ca</sub> to improve glomerular lesions in another way.</p><p>TGF-<italic>&#x003b2;</italic> is one of the central factors in the occurrence and development of DKD. It can induce the proliferation of mesangial cells and the secretion of collagen and even directly induce the synthesis of ECM such as Col and FN from transcriptional level to promote the process of renal fibrosis [<xref rid="B26" ref-type="bibr">26</xref>]. At present, three subtypes of TGF-<italic>&#x003b2;</italic>1, 2, and 3 have been identified in mammals [<xref rid="B27" ref-type="bibr">27</xref>], among which TGF-<italic>&#x003b2;</italic>1 is most closely related to kidney [<xref rid="B28" ref-type="bibr">28</xref>]. Smad2 and 3, as the main downstream effector proteins of TGF-<italic>&#x003b2;</italic> signaling pathway, can bind to Smad4 after phosphorylation and then transfect into nuclear regulatory gene transcription. Among them, Smad3 plays a more important role and is recognized as a fibrogenic factor [<xref rid="B29" ref-type="bibr">29</xref>].</p></sec><sec id="sec5"><title>5. Conclusion</title><p>TGF-<italic>&#x003b2;</italic>1 has similar effects to NS11021, which can promote the proliferation, migration, and apoptosis of HBZY-1 cells and promote the secretion of Col IV and FN in ECM. And SB431542 is similar to Tet and BK<sub>Ca</sub>-siRNA, which suggests that BK<sub>Ca</sub> may be related to TGF-<italic>&#x003b2;</italic>1/Smad2/3 pathway. Further experiments showed that NS11021&#x02009;+&#x02009;SB431542 could inhibit the proliferation, migration, and apoptosis of HBZY-1 cells and the secretion of Col IV and FN in ECM. On the contrary, Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 could promote the proliferation, migration, and apoptosis of HBZY-1 cells and the secretion of Col IV and FN in ECM, suggesting that TGF-<italic>&#x003b2;</italic>1/Smad2/3 and BK<sub>Ca</sub> regulate the proliferation, migration, and apoptosis of HBZY-1 cells and the secretion of Col IV and FN are the same signaling pathway. TGF-<italic>&#x003b2;</italic>1/Smad2/3 is downstream of BK<sub>Ca</sub>. Through the development of specific agonists or blockers of BK<sub>Ca</sub> to regulate the expression and function of BK<sub>Ca</sub>, it may provide a new therapeutic direction for DKD.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the Project of Doctoral Research Initiation Foundation of Affiliated Hospital of Southwest Medical University (No. 18104), the Project of Southwest Medical University (No. 31260), and the Project of Sichuan Health Department (No. 050102).</p></ack><sec sec-type="data-availability"><title>Data Availability</title><p>The datasets used and/or analyzed in the study are available from the corresponding author on reasonable request.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec><title>Authors' Contributions</title><p>ZGW and MJC contributed to the design of the study. WXY, MQS, and YKS performed the experiments. XXW analyzed the data. ZGW, YWX, and MJC wrote sections of the manuscript. The final version of the manuscript has been read and approved by all authors. Zhigui Wu and Wenxian Yin authors are contributed equally to this work.</p></sec><sec sec-type="supplementary-material" id="supplementary-material-1"><title>Supplementary Materials</title><supplementary-material content-type="local-data" id="supp-1"><label>Supplementary Materials</label><caption><p>Supplementary Figures 1 and 2: the results of siRNA interference. Supplementary Figure 3: detailed results of different concentrations of NS11021 and Tet to treat cells.</p></caption><media xlink:href="3260728.f1.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alicic</surname><given-names>R. Z.</given-names></name><name><surname>Johnson</surname><given-names>E. J.</given-names></name><name><surname>Tuttle</surname><given-names>K. R.</given-names></name></person-group><article-title>SGLT2 inhibition for the prevention and treatment of diabetic kidney disease: a review</article-title><source><italic toggle="yes">American Journal of Kidney Diseases</italic></source><year>2018</year><volume>72</volume><issue>2</issue><fpage>267</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2018.03.022</pub-id><pub-id pub-id-type="other">2-s2.0-85047818222</pub-id><pub-id pub-id-type="pmid">29866460</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malaga-Dieguez</surname><given-names>L.</given-names></name><name><surname>Spencer</surname><given-names>R.</given-names></name><name><surname>Pehrson</surname><given-names>L. J.</given-names></name><etal/></person-group><article-title>Early manifestations of renal disease in patients with tuberous sclerosis complex</article-title><source><italic toggle="yes">International Journal of Nephrology and Renovascular Disease</italic></source><year>2017</year><volume>10</volume><fpage>91</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.2147/ijnrd.s123638</pub-id><pub-id pub-id-type="other">2-s2.0-85020376508</pub-id><pub-id pub-id-type="pmid">28496353</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.-L.</given-names></name><name><surname>Gan</surname><given-names>X.-X.</given-names></name><name><surname>Jun</surname><given-names>N.</given-names></name><etal/></person-group><article-title>SND p102 promotes extracellular matrix accumulation and cell proliferation in rat glomerular mesangial cells via the AT1R/ERK/Smad3 pathway</article-title><source><italic toggle="yes">Acta Pharmacologica Sinica</italic></source><year>2018</year><volume>39</volume><issue>9</issue><fpage>1513</fpage><lpage>1521</lpage><pub-id pub-id-type="doi">10.1038/aps.2017.184</pub-id><pub-id pub-id-type="other">2-s2.0-85052292554</pub-id><pub-id pub-id-type="pmid">30150789</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vavrinec</surname><given-names>P.</given-names></name><name><surname>Henning</surname><given-names>R.</given-names></name><name><surname>Landheer</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Vildagliptin restores renal myogenic function and attenuates renal sclerosis independently of effects on blood glucose or proteinuria in zucker diabetic fatty rat</article-title><source><italic toggle="yes">Current Vascular Pharmacology</italic></source><year>2014</year><volume>12</volume><issue>6</issue><fpage>836</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.2174/15701611113116660151</pub-id><pub-id pub-id-type="other">2-s2.0-84926297509</pub-id><pub-id pub-id-type="pmid">24066937</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tung</surname><given-names>C.-W.</given-names></name><name><surname>Hsu</surname><given-names>Y.-C.</given-names></name><name><surname>au</surname><given-names>Y.-H.</given-names></name><name><surname>Chang</surname><given-names>P.-J.</given-names></name><name><surname>Lin</surname><given-names>C.-L.</given-names></name></person-group><article-title>Glomerular mesangial cell and podocyte injuries in diabetic nephropathy</article-title><source><italic toggle="yes">Nephrology</italic></source><year>2018</year><volume>23</volume><issue>4</issue><fpage>32</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1111/nep.13451</pub-id><pub-id pub-id-type="other">2-s2.0-85054559042</pub-id><pub-id pub-id-type="pmid">30298646</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>J.</given-names></name><name><surname>Lan</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Large-conductance calcium-activated potassium channels in glomerulus: from cell signal integration to disease</article-title><source><italic toggle="yes">Frontiers in Physiology</italic></source><year>2016</year><volume>7</volume><fpage>p. 248</fpage><pub-id pub-id-type="doi">10.3389/fphys.2016.00248</pub-id><pub-id pub-id-type="other">2-s2.0-84977659035</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delanaye</surname><given-names>P.</given-names></name><name><surname>Scheen</surname><given-names>A. J.</given-names></name></person-group><article-title>Preventing and treating kidney disease in patients with type 2 diabetes</article-title><source><italic toggle="yes">Expert Opinion on Pharmacotherapy</italic></source><year>2019</year><volume>20</volume><issue>3</issue><fpage>277</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1080/14656566.2018.1551362</pub-id><pub-id pub-id-type="other">2-s2.0-85056358005</pub-id><pub-id pub-id-type="pmid">30462565</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehling</surname><given-names>P.</given-names></name><name><surname>Cerina</surname><given-names>M.</given-names></name><name><surname>Meuth</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Ca<sub>2</sub>+-dependent large conductance K+ currents in thalamocortical relay neurons of different rat strains</article-title><source><italic toggle="yes">Pfl&#x000fc;gers Archiv&#x02014;European Journal of Physiology</italic></source><year>2013</year><volume>465</volume><issue>4</issue><fpage>469</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1007/s00424-012-1188-6</pub-id><pub-id pub-id-type="other">2-s2.0-84877799457</pub-id><pub-id pub-id-type="pmid">23207578</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Luo</surname><given-names>N.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Inhibition of BKCa channel currents in vascular smooth muscle cells contributes to HBOC-induced vasoconstriction</article-title><source><italic toggle="yes">Artificial Cells, Nanomedicine, and Biotechnology</italic></source><year>2016</year><volume>44</volume><issue>1</issue><fpage>178</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.3109/21691401.2014.930746</pub-id><pub-id pub-id-type="other">2-s2.0-84971607393</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x02019;Gouemo</surname><given-names>P.</given-names></name></person-group><article-title>BKCa channel dysfunction in neurological diseases</article-title><source><italic toggle="yes">Frontiers in Physiology</italic></source><year>2014</year><volume>5</volume><fpage>p. 373</fpage><pub-id pub-id-type="doi">10.3389/fphys.2014.00373</pub-id><pub-id pub-id-type="other">2-s2.0-84907948759</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayad</surname><given-names>O.</given-names></name><name><surname>Magaud</surname><given-names>C.</given-names></name><name><surname>Sebille</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Functional BKCa channel in human resident cardiac stem cells expressing W8B2</article-title><source><italic toggle="yes">The FEBS Journal</italic></source><year>2018</year><volume>285</volume><issue>3</issue><fpage>518</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1111/febs.14352</pub-id><pub-id pub-id-type="other">2-s2.0-85039172751</pub-id><pub-id pub-id-type="pmid">29211342</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>G. F.</given-names></name><name><surname>Castillo</surname><given-names>K.</given-names></name><name><surname>Enrique</surname><given-names>N.</given-names></name><etal/></person-group><article-title>A BK (Slo1) channel journey from molecule to physiology</article-title><source><italic toggle="yes">Channels</italic></source><year>2013</year><volume>7</volume><issue>6</issue><fpage>442</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.4161/chan.26242</pub-id><pub-id pub-id-type="other">2-s2.0-84886994171</pub-id><pub-id pub-id-type="pmid">24025517</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piwkowska</surname><given-names>A.</given-names></name><name><surname>Rogacka</surname><given-names>D.</given-names></name><name><surname>Audzeyenka</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Insulin increases glomerular filtration barrier permeability through PKGI<italic>&#x003b1;</italic>-dependent mobilization of BKCa channels in cultured rat podocytes</article-title><source><italic toggle="yes">BBA&#x02014;Molecular Basis of Disease</italic></source><year>2015</year><volume>1852</volume><issue>8</issue><fpage>1599</fpage><lpage>1609</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2015.04.024</pub-id><pub-id pub-id-type="other">2-s2.0-84928978788</pub-id><pub-id pub-id-type="pmid">25952906</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hongxiao</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Chuanbao</surname><given-names>C.</given-names></name><etal/></person-group><article-title>The expression of BKca <italic>&#x003b1;</italic>, <italic>&#x003b2;</italic>1 subunits in mesenteric artery smooth muscle cells of type 2 diabetic rats</article-title><source><italic toggle="yes">Chinese Journal of Modern Medicine</italic></source><year>2016</year><volume>26</volume><issue>16</issue><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>A. S.</given-names></name><name><surname>Hathaway</surname><given-names>C. K.</given-names></name><name><surname>au</surname><given-names>O.</given-names></name><name><surname>Kakoki</surname><given-names>M.</given-names></name></person-group><article-title>Transforming growth factor-<italic>&#x003b2;</italic>1 and diabetic nephropathy</article-title><source><italic toggle="yes">American Journal of Physiology-Renal Physiology</italic></source><year>2016</year><volume>310</volume><issue>8</issue><fpage>F689</fpage><lpage>F696</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00502.2015</pub-id><pub-id pub-id-type="other">2-s2.0-84983792423</pub-id><pub-id pub-id-type="pmid">26719364</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>au</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name></person-group><article-title>miR-133b and miR-199b knockdown attenuate TGF-<italic>&#x003b2;</italic>1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy</article-title><source><italic toggle="yes">European Journal of Pharmacology</italic></source><year>2018</year><volume>837</volume><fpage>96</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2018.08.022</pub-id><pub-id pub-id-type="other">2-s2.0-85053020216</pub-id><pub-id pub-id-type="pmid">30125566</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>M. G.</given-names></name><name><surname>He</surname><given-names>W. M.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>JiaWeiDangGui decoction ameliorates proteinuria and kidney injury in adriamycin-induced rat by blockade of TGF-beta/Smad signaling</article-title><source><italic toggle="yes">Evidence-Based Complementary and Alternative Medicine</italic></source><year>2016</year><volume>2016</volume><fpage>11</fpage><pub-id pub-id-type="publisher-id">5031890</pub-id><pub-id pub-id-type="doi">10.1155/2016/5031890</pub-id><pub-id pub-id-type="other">2-s2.0-84976559162</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varadaraj</surname><given-names>A.</given-names></name><name><surname>Jenkins</surname><given-names>L. M.</given-names></name><name><surname>Chanda</surname><given-names>A.</given-names></name><etal/></person-group><article-title>TGF-<italic>&#x003b2;</italic> triggers rapid fibrillogenesis via a novel T<italic>&#x003b2;</italic>RII-dependent fibronectin-trafficking mechanism</article-title><source><italic toggle="yes">Molecular Biology of the Cell</italic></source><year>2017</year><volume>28</volume><issue>9</issue><fpage>1195</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1091/mbc.e16-08-0601</pub-id><pub-id pub-id-type="other">2-s2.0-85018325076</pub-id><pub-id pub-id-type="pmid">28298487</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borchert</surname><given-names>G. H.</given-names></name><name><surname>Hlav&#x000e1;&#x0010d;kov&#x000e1;</surname><given-names>M.</given-names></name><name><surname>Kol&#x000e1;&#x00159;</surname><given-names>F.</given-names></name></person-group><article-title>Pharmacological activation of mitochondrial BKCa channels protects isolated cardiomyocytes against simulated reperfusion-induced injury</article-title><source><italic toggle="yes">Experimental Biology and Medicine</italic></source><year>2013</year><volume>238</volume><issue>2</issue><fpage>233</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1177/1535370212474596</pub-id><pub-id pub-id-type="other">2-s2.0-84877660097</pub-id><pub-id pub-id-type="pmid">23576804</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S. N.</given-names></name><name><surname>Li</surname><given-names>H. F.</given-names></name><name><surname>Lo</surname><given-names>Y. C.</given-names></name></person-group><article-title>Characterization of tetrandrine-induced inhibition of large-conductance calcium-activated potassium channels in a human endothelial cell line (HUV-EC-C)</article-title><source><italic toggle="yes">Journal of Pharmacology and Experimental Therapeutics</italic></source><year>2000</year><volume>292</volume><issue>1</issue><fpage>188</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">10604947</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>T. M. A.</given-names></name><name><surname>Stone</surname><given-names>N. R.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Chemical enhancement of in vitro and in vivo direct cardiac reprogramming</article-title><source><italic toggle="yes">Circulation</italic></source><year>2017</year><volume>135</volume><issue>10</issue><fpage>978</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1161/circulationaha.116.024692</pub-id><pub-id pub-id-type="other">2-s2.0-85011006666</pub-id><pub-id pub-id-type="pmid">27834668</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal/></person-group><article-title>The inhibitory effect of angiotensin II on BKCa channels in podocytes via oxidative stress</article-title><source><italic toggle="yes">Molecular and Cellular Biochemistry</italic></source><year>2015</year><volume>398</volume><issue>1-2</issue><fpage>217</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1007/s11010-014-2221-1</pub-id><pub-id pub-id-type="other">2-s2.0-84922003803</pub-id><pub-id pub-id-type="pmid">25234195</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donegan</surname><given-names>D.</given-names></name><name><surname>Bale</surname><given-names>L. K.</given-names></name><name><surname>Conover</surname><given-names>C. A.</given-names></name></person-group><article-title>PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy</article-title><source><italic toggle="yes">Journal of Endocrinology</italic></source><year>2016</year><volume>231</volume><issue>1</issue><fpage>71</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1530/joe-16-0205</pub-id><pub-id pub-id-type="other">2-s2.0-84991491952</pub-id><pub-id pub-id-type="pmid">27519211</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kriz</surname><given-names>W.</given-names></name><name><surname>L&#x000f6;wen</surname><given-names>J.</given-names></name><name><surname>Federico</surname><given-names>G.</given-names></name><name><surname>van den Born</surname><given-names>J.</given-names></name><name><surname>Gr&#x000f6;ne</surname><given-names>E.</given-names></name><name><surname>Gr&#x000f6;ne</surname><given-names>H. J.</given-names></name></person-group><article-title>Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy</article-title><source><italic toggle="yes">American Journal of Physiology-Renal Physiology</italic></source><year>2017</year><volume>312</volume><issue>6</issue><fpage>F1101</fpage><lpage>F1111</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00020.2017</pub-id><pub-id pub-id-type="other">2-s2.0-85020453192</pub-id><pub-id pub-id-type="pmid">28228399</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>G.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Overexpression of the FoxO1 ameliorates mesangial cell dysfunction in male diabetic rats</article-title><source><italic toggle="yes">Molecular Endocrinology</italic></source><year>2015</year><volume>29</volume><issue>7</issue><fpage>1080</fpage><lpage>1091</lpage><pub-id pub-id-type="doi">10.1210/me.2014-1372</pub-id><pub-id pub-id-type="other">2-s2.0-84936061468</pub-id><pub-id pub-id-type="pmid">26029993</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>S. E.</given-names></name><name><surname>Jo</surname><given-names>H. J.</given-names></name><name><surname>au</surname><given-names>Y.-W.</given-names></name><name><surname>Cho</surname><given-names>Y.-J.</given-names></name><name><surname>Kim</surname><given-names>J.-R.</given-names></name><name><surname>Park</surname><given-names>S.-Y.</given-names></name></person-group><article-title>Delphinidin prevents high glucose-induced cell proliferation and collagen synthesis by inhibition of NOX-1 and mitochondrial superoxide in mesangial cells</article-title><source><italic toggle="yes">Journal of Pharmacological Sciences</italic></source><year>2016</year><volume>130</volume><issue>4</issue><fpage>235</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.jphs.2016.03.005</pub-id><pub-id pub-id-type="other">2-s2.0-84966351204</pub-id><pub-id pub-id-type="pmid">27103328</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtman</surname><given-names>M. K.</given-names></name><name><surname>Otero-Vinas</surname><given-names>M.</given-names></name><name><surname>Falanga</surname><given-names>V.</given-names></name></person-group><article-title>Transforming growth factor beta (TGF-<italic>&#x003b2;</italic>) isoforms in wound healing and fibrosis</article-title><source><italic toggle="yes">Wound Repair and Regeneration</italic></source><year>2016</year><volume>24</volume><issue>2</issue><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1111/wrr.12398</pub-id><pub-id pub-id-type="other">2-s2.0-84959472278</pub-id><pub-id pub-id-type="pmid">26704519</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Deletion of diacylglycerol-responsive TRPC genes attenuates diabetic nephropathy by inhibiting activation of the TGFbeta1 signaling pathway</article-title><source><italic toggle="yes">American Journal of Translational Research</italic></source><year>2017</year><volume>9</volume><issue>12</issue><fpage>5619</fpage><lpage>5630</lpage><pub-id pub-id-type="pmid">29312514</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>P. M.</given-names></name><name><surname>Nikolic-Paterson</surname><given-names>D. J.</given-names></name><name><surname>Lan</surname><given-names>H. Y.</given-names></name></person-group><article-title>Macrophages: versatile players in renal inflammation and fibrosis</article-title><source><italic toggle="yes">Nature Reviews Nephrology</italic></source><year>2019</year><volume>15</volume><issue>3</issue><fpage>144</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1038/s41581-019-0110-2</pub-id><pub-id pub-id-type="other">2-s2.0-85060684529</pub-id><pub-id pub-id-type="pmid">30692665</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The effect of different interventions on cell viability. <sup><italic>&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.05, <sup><italic>&#x02217;&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.01 vs. NG group; <sup>#</sup><italic>P</italic> &#x0003c; 0.05, <sup>##</sup><italic>P</italic> &#x0003c; 0.01 vs. HG group.</p></caption><graphic xlink:href="IJE2020-3260728.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>The effect of different interventions on cell migration ability was observed by an inverted microscope (&#x000d7;100). (a) NG group; (b) HG group; (c) HG&#x02009;+&#x02009;NS11021 group; (d) HG&#x02009;+&#x02009;Tet group; (e) HG&#x02009;+&#x02009;BK<sub>Ca</sub>-siRNA group; (f) HG&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 group; (g) HG&#x02009;+&#x02009;SB431542 group; (h) HG&#x02009;+&#x02009;NS11021&#x02009;+&#x02009;SB431542 group; (i) HG&#x02009;+&#x02009;Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 group; (j) degree of cell scratch healing in different intervention groups. <sup><italic>&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.05, <sup><italic>&#x02217;&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.01 vs. NG group; <sup>#</sup><italic>P</italic> &#x0003c; 0.05, <sup>##</sup><italic>P</italic> &#x0003c; 0.01 vs. HG group.</p></caption><graphic xlink:href="IJE2020-3260728.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Apoptosis of each intervention group after Hoechst staining was observed by a fluorescence inversion microscope (&#x000d7;400). (a) NG group; (b) HG group; (c) HG&#x02009;+&#x02009;NS11021 group; (d) HG&#x02009;+&#x02009;Tet group; (e) HG&#x02009;+&#x02009;BK<sub>Ca</sub>-siRNA group; (f) HG&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 group; (g) HG&#x02009;+&#x02009;SB431542 group; (h) HG&#x02009;+&#x02009;NS11021&#x02009;+&#x02009;SB431542 group; (i) HG&#x02009;+&#x02009;Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 group. <italic>n</italic>&#x02009;=&#x02009;6.</p></caption><graphic xlink:href="IJE2020-3260728.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>The effects of interventions on apoptosis were examined by flow cytometry. (a) NG group; (b) HG group; (c) HG&#x02009;+&#x02009;NS11021 group; (d) HG&#x02009;+&#x02009;Tet group; (e) HG&#x02009;+&#x02009;BK<sub>Ca</sub>-siRNA group; (f) HG&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 group; (g) HG&#x02009;+&#x02009;SB431542 group; (h) HG&#x02009;+&#x02009;NS11021&#x02009;+&#x02009;SB431542 group; (i) HG&#x02009;+&#x02009;Tet&#x02009;+&#x02009;TGF-<italic>&#x003b2;</italic>1 group; (j) apoptosis rate in different intervention groups. <sup><italic>&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.05, <sup><italic>&#x02217;&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.01 vs. NG group; <sup>#</sup><italic>P</italic> &#x0003c; 0.05, <sup>##</sup><italic>P</italic> &#x0003c; 0.01 vs. HG group. <italic>n</italic>&#x02009;=&#x02009;6.</p></caption><graphic xlink:href="IJE2020-3260728.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>The effects of each group on the expression of BKCa-<italic>&#x003b1;</italic> and <italic>&#x003b2;</italic> protein were detected by Western blotting. <sup><italic>&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.05, <sup><italic>&#x02217;&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.01 vs. NG group; <sup>#</sup><italic>P</italic> &#x0003c; 0.05, <sup>##</sup><italic>P</italic> &#x0003c; 0.01 vs. HG group; <sup>&#x025b3;&#x025b3;</sup><italic>P</italic> &#x0003c; 0.01. <italic>n</italic>&#x02009;=&#x02009;6.</p></caption><graphic xlink:href="IJE2020-3260728.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>The effects of each group on the expression of collagen IV and fibronectin were detected by Western blotting. <sup><italic>&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.05, <sup><italic>&#x02217;&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.01 vs. NG group; <sup>#</sup><italic>P</italic> &#x0003c; 0.05, <sup>##</sup><italic>P</italic> &#x0003c; 0.01 vs. HG group; <sup>&#x025b3;&#x025b3;</sup><italic>P</italic> &#x0003c; 0.01.<italic>n</italic>&#x02009;=&#x02009;6.</p></caption><graphic xlink:href="IJE2020-3260728.006"/></fig><fig id="fig7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>The expression of TGF-<italic>&#x003b2;</italic>1 and Smad2/3 in each intervention group. (a) Quantitative map of TGF-<italic>&#x003b2;</italic>1 concentration in each group; (b) quantitative map of Smad 2/3 concentration in each group <sup><italic>&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.05, <sup><italic>&#x02217;&#x02217;</italic></sup><italic>P</italic> &#x0003c; 0.01 vs. NG group;<sup>#</sup><italic>P</italic> &#x0003c; 0.05, <sup>##</sup><italic>P</italic> &#x0003c; 0.01 vs. HG group.</p></caption><graphic xlink:href="IJE2020-3260728.007"/></fig></floats-group></article>